2015
DOI: 10.1016/j.ajhg.2014.12.026
|View full text |Cite
|
Sign up to set email alerts
|

Loss-of-Function Mutations in CAST Cause Peeling Skin, Leukonychia, Acral Punctate Keratoses, Cheilitis, and Knuckle Pads

Abstract: Calpastatin is an endogenous specific inhibitor of calpain, a calcium-dependent cysteine protease. Here we show that loss-of-function mutations in calpastatin (CAST) are the genetic causes of an autosomal-recessive condition characterized by generalized peeling skin, leukonychia, acral punctate keratoses, cheilitis, and knuckle pads, which we propose to be given the acronym PLACK syndrome. In affected individuals with PLACK syndrome from three families of different ethnicities, we identified homozygous mutatio… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
4
1

Citation Types

1
37
0
1

Year Published

2015
2015
2024
2024

Publication Types

Select...
3
3
1

Relationship

0
7

Authors

Journals

citations
Cited by 38 publications
(39 citation statements)
references
References 36 publications
1
37
0
1
Order By: Relevance
“…Other forms of PSS are associated with systemic manifestations, such as SAM syndrome (MIM615508) or Netherton syndrome (MIM256500) . More recently, a complex phenotype termed PLACK ( p eeling skin, l euconychia, a cral punctate keratosis, c heilitis and k nuckle pads) syndrome has been shown to result from loss‐of‐function mutations in CAST , the gene encoding calpastatin, a specific inhibitor of calpains, which function as a calcium‐dependent cysteine proteases …”
Section: Clinical and Molecular Characteristics Of Plack Syndrome Repmentioning
confidence: 99%
See 3 more Smart Citations
“…Other forms of PSS are associated with systemic manifestations, such as SAM syndrome (MIM615508) or Netherton syndrome (MIM256500) . More recently, a complex phenotype termed PLACK ( p eeling skin, l euconychia, a cral punctate keratosis, c heilitis and k nuckle pads) syndrome has been shown to result from loss‐of‐function mutations in CAST , the gene encoding calpastatin, a specific inhibitor of calpains, which function as a calcium‐dependent cysteine proteases …”
Section: Clinical and Molecular Characteristics Of Plack Syndrome Repmentioning
confidence: 99%
“…PLACK syndrome seems to be associated with genetic homogeneity, as all causative mutations reported to date in this rare disorder are loss‐of‐function mutations in CAST (Fig. c) , encoding calpastatin, a calpain inhibitor . Calpains are calcium‐dependent intracellular cysteine proteases normally expressed in human skin.…”
Section: Clinical and Molecular Characteristics Of Plack Syndrome Repmentioning
confidence: 99%
See 2 more Smart Citations
“…Leukonychia in syndromic condition has also been reported in a number of studies [11,18,19]. A familial Bart-Pumphrey Syndrome-associated leukonychia was described, co-segregating with autosomal recessive missense mutation in Gap junction beta-2 (GJB2) gene [18].…”
Section: Introductionmentioning
confidence: 99%